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INTRODUCTION 
 
Cardio- and cerebrovascular diseases represent the major 
causes of death (35.8%) in the world according to recent data 
of World Health Organisation. The underlying cause in these 
cases is the formation of intravascular thrombi (composed of 
blood cells and plasma components embedded in a fibrin 
network), blocking the supply of oxygen and nutrients, 
therefore leading to the damage of the respective tissue. The 
fact that degradation of the fibrin scaffold (Fig. 1.) itself is 
sufficient for the dissolution of thrombi is exploited by 
Figure 1. The two-step process of fibrinolysis. I.: activation 
of the inactive precursor plasminogen. The physiologically 
and therapeutically most relevant plasminogen activator is 
tPA (tissue-type plasminogen activator). II.: Fibrin 
degradation catalysed by the active enzyme, plasmin. 
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therapeutic thrombolysis, representing a modality aiming the 
reconstitution of blood flow.   
However, thrombolytic therapy often proves to be 
inefficient in the long term, and is accompanied by a serious 
risk for bleedings as a side effect. Improvement of current 
thrombolytic therapeutic protocols requires determination of 
the factors influencing the efficiency of the respective enzymes 
in the dissolution of thrombi.  
This thesis focuses on two of the numerous factors: 
mechanical stress to which fibrin formed in the circulation is 
exposed; and a recently recognized scaffold of venous and 
arterial thrombi: neutrophil extracellular traps (NETs) 
representing a web-like meshwork (Fig. 2.) composed of DNA, 
histones and granular components released from granulocytes 
as a response to various (inflammatory) stimuli.   
Figure 2. SEM (scanning electron microscopic) images of 
neutrophil extracellular traps released by activated 
neutrophils. Scale bar: 1 µm. 
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OBJECTIVES 
 
Aims of the studies on the effects of mechanical stress: 
-To examine thrombi from patients to seek for possible effects 
of intravascular mechanical forces 
-To build a model system in which fibrin structure 
approximates that of the external region of certain thrombi 
exposed to shear stress exerted by blood flow 
-To assess structural and lytic properties of stretched fibrin 
clots 
 
Aims of the studies on the effects of NET components: 
-To detect DNA and histone content in arterial thrombi from 
patients 
-To investigate the effect of NET components on fibrin 
structure in pure fibrin clots and more complex plasma systems 
-To assess mechanical properties of clots containing DNA, 
histones, or their combinations 
-To study the process of fibrinolysis in plasma clots containing 
DNA ± histones or NETs derived from activated neutrophils 
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MATERIALS AND METHODS 
 
Patients 
Thirteen patients with no inherited or acquired thrombophilic 
state were enrolled in the study. At the time of thrombectomy 
all patients received heparin treatment. Written informed 
consent was obtained from all patients and the study protocol 
was approved by the institutional and regional ethical board. 
 
Scanning electron microscopic imaging  
Pieces of thrombi from patients or fibrin- and plasma clots 
were fixed in glutaraldehyde, dehydrated, critical point dried 
with CO2, and sputter coated with gold. Images taken with 
scanning electron microscope EVO40 were analysed to 
determine the diameter of the fibrin fibres and the area of the 
fibrin network pores using self-designed scripts running under 
the Image Processing TOOLBOX v. 7.0 of Matlab R2010a.  
 
Immunohistochemistry 
Cryosections of thrombi frozen immediately after surgery were 
attached to lysine-coated slides. Sections were fixed in acetone 
and air-dried, followed by incubation with bovine serum 
albumin to eliminate nonspecific binding of antibodies. 
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Subsequently, slides were washed and DNA was stained with 
TOTO-3

. For double immunostaining the sections were 
incubated with mouse monoclonal anti-human fibrin antibody, 
rabbit anti-human histone H1 antibody, fluorescent goat anti-
mouse immunoglobulin antibody and fluorescent goat anti-
rabbit immunoglobulin antibody. Confocal fluorescent images 
were taken using a Zeiss LSM710 confocal laser scanning 
microscope equipped with a 20x1.4 objective. 
 
Clot permeability assays 
Fibrinogen or human citrated plasma supplemented with CaCl2 
± additives (DNA ± histone) were clotted with thrombin in 
plastic pipette tips. Thereafter, 10 mM 4-(2-hydroxiethyl)-1- 
piperazin-ethane-sulphonic acid (HEPES) buffer pH 7.4 
containing 150 mM NaCl was permeated through the clots with 
a constant head pressure. KS (permeability coefficient or 
Darcy-constant) was calculated from the equation
. .
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where Q = permeated volume of buffer (cm
3
);  = viscosity of 
buffer (N.s.cm
-2
); L = clot length (cm); A = average cross-
sectional area of the clot (cm
2
); t = time (s); ΔP = pressure drop 
(N.cm
-2
). 
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Evaluation of fibrin rigidity 
Fibrinogen pre-mixed with DNA ± histones was clotted with 
thrombin. The clotting mixture was transferred to the plate of 
HAAKE RheoStress 1 oscillation rheometer thermostatted at 
37 °C. Measurements of storage modulus (G’) and loss 
modulus (G’’) were taken at 1 Hz in the course of 15 min with 
HAAKE RheoWin data manager software v. 3.50.0012. 
Following this 15-min clotting phase, determination of the flow 
limit of the fibrin gels was performed in the same samples. 
  
Isothermal titration calorimetry (ITC) 
The enthalpy changes accompanying the interaction of 
DNA/histone and fibrin degradation products (FDP), 
fibrinogen or plasminogen were measured using isothermal 
titration method on VP-ITC microcalorimeter. The proteins 
were injected in a series of aliquots into the cell of the 
calorimeter containing DNA or histones and the heat increment 
of each addition was recorded by the instrument. The heat data 
for the interactions were evaluated according to the single-site 
algorithm with ITC Data Analysis 7.0 software.  
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Confocal microscopic imaging 
Clots were prepared from fibrinogen or human plasma 
supplemented with Alexa Fluor® 546-conjugated fibrinogen 
plasminogen and clotted with thrombin in uncoated IBIDI VI 
0.4 μ-slides. In certain cases, human granulocyte DNA and/or 
histone were also added to the mixture. Thereafter tPA-GFP or 
tPA-YFP supplemented with plasminogen was added to the 
edge of the clot and the fluorescence was monitored with 
LSM710 taking sequential images of the fluid-fibrin interface 
with identical exposures and laser intensities using a Plan-
NeofluarX20/0.5 objective. 
 
Plasminogen activation assays 
In 96-well microtiter plates, plasma supplemented with CaCl2 
± DNA and/or histone was clotted with thrombin. tPA and 
chromogenic plasmin substrate Spectrozyme-Plasmin (SPPL) 
were pipetted on the surface of the clot. The forming plasmin 
generated p-nitroaniline, the absorbance of which was 
continuously recorded at 405 nm (A405) with Zenith 200rt 
spectrophotometer.  
To detect plasminogen activation on a stretched 
substrate, plasminogen was added to fibrinogen before clotting 
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in elastic silicon tubes. After stretching the tubes, the shell 
filled with buffer around the retracted fibrin was replaced with 
tPA. After incubation at 37 °C for various times, the total fluid 
phase was removed and its volume was measured. The 
concentration of plasmin in the fluid phase was determined 
from the enzyme activity measured on SPPL. 
 
Turbidimetry assays                                                                                                                 
Plasma supplemented with plasminogen, CaCl2 and DNA ± 
histone or (activated) granulocytes were clotted with thrombin 
in 96-well microtiter plates. Lysis was initiated by addition of 
tPA. Clot dissolution was followed by measuring the light 
absorbance at 340 nm at 37 °C with a Zenyth 200rt microplate 
spectrophotometer. The time needed to reduce the turbidity of 
the clot to a given fraction of the maximal value (T50 to reach 
0.5Amax, T10 to reach 0.1Amax) was used as a quantitative 
parameter of fibrinolytic activity. 
 
Examination of clot lysis in microslide channels 
Mixtures of plasma supplemented with CaCl2, thrombin and 
DNA ± histone were pipetted into channnels of IBIDI slides. 
Following clotting, plasmin was added, and lysis was followed 
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by time lapse photoscanning of the transparent fluid/opaque 
clot boundary. 
 
Enzyme inactivation assays 
A mixture of plasmin, CaCl2, defibrinogenated plasma ± DNA 
were incubated at room temperature for 10 seconds, and then 
diluted in SPPL. The change of absorbance at 405 nm was 
measured with a Beckman DU 7500 spectrophotometer.  
 Mixtures of antithrombin, thrombin, histone/DNA ± 
heparin were incubated for various times at room temperature. 
Residual thrombin-induced clotting time was measured with a 
coagulometer KC-1A at 37 °C after addition of fibrinogen. 
  
Statistical procedures 
Theoretical distributions of the data on fibre diameter and pore 
area measured in SEM images were fitted to the empirical data 
sets and compared using Kuiper’s test and Monte Carlo 
simulation procedures. The statistical evaluation of other 
experimental measurements in this work was performed with 
the Kolmogorov–Smirnov test (Statistical TOOLBOX 7.3 of 
Matlab); values of p<0.05 were considered statistically 
significant.  
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RESULTS 
 
Stressed fibrin lysis 
Structural features of thrombi from patients and stretched clots 
While in all cases the core of the ex vivo thrombi contained a 
random fibrin network, in 4 specimens the gel pores on the 
surface were elongated in one direction resulting in 
longitudinal alignment of fibres accompanied by their tighter 
packing in the transverse direction. Morphometric analysis of 
SEM images showed that both fibre diameter and pore area 
were lower in these areas compared to the interior regions. 
 Since stretching of fibrin clots changed the arrangement 
of the fibres to a similar pattern (both fibre diameter and pore 
area were decreased, see Fig. 3.), stretched fibrin was used as a 
model system to evaluate the impact of mechanical stress on 
the structure and lytic susceptibility of fibrin. 
 
Figure 3. SEM images of fibrin clots. Clots were prepared in 
elastic silicon tubes and stretched to the indicated extent. Scale 
bar: 2 µm.  
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Lysis of stretched fibrin 
The amount of plasmin generated by tPA on the surface of 
fibrin (containing plasminogen) and released in the fluid phase 
decreased two- to three-fold, if stretched fibrin was used as a 
template instead of its non-stretched counterpart. In the 
presence of SPPL, which is able to penetrate into the clot, the 
detected plasmin activity was similarly lower on stretched 
fibrin, showing that the effect of the modified fibrin structure 
on the apparent plasmin generation is based on changes in 
plasminogen activation rather than in plasmin retention in the 
clot. The release of soluble FDP from stretched fibrin clots was 
also slower.  
In order to evaluate separately the direct fibrin 
solubilisation by plasmin, plasminogen-free fibrin clots were 
treated with plasmin and the course of their dissolution was 
monitored. The SEM images of non-stretched fibrin digested 
for 45 min with plasmin showed many truncated fibres in the 
remnant fibrin, whereas only few fibres presented signs of 
digestion in the stretched fibrin. 
The mechanism of fibrinolytic resistance induced by 
stretching of fibrin was approached with the help of fluorescent 
confocal microscopy (Fig. 4.). When tPA-GFP was applied to 
the surface of non-stretched fibrin, a distinct zone of tPA 
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accumulation was formed at the fluid/fibrin interface within 
several minutes, which moved a distance of about 75 µm in 50 
min as plasmin was formed and it dissolved the fibrin. This 
interfacial tPA-enriched zone on the surface of stretched fibrin 
did not move at all in the first hour of observation. Thus, the 
modified ultrastructure of fibrin in clots exposed to mechanical 
stress impedes tPA binding/penetration into fibrin and delays 
the lytic process in this experimental setup. 
 
Figure 4. Lysis of fibrin monitored with confocal laser 
microscopy. Fibrinogen containing Alexa546-labeled 
fibrinogen and plasminogen was clotted with thrombin and 
stretched as indicated. tPA-GFP was added to fibrin and the 
fluid/fibrin interface was monitored with a confocal laser 
scanning microscope using dual fluorescent tracing: green 
channel for tPA and red channel for fibrin (the third panel in 
each image represents the overlay of the two channels), scale 
bar = 50 µm. The time after addition of tPA-GFP is indicated.  
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Effects of NET components on clot structure and lysis 
Thrombi from patients 
Surgically removed thrombi analysed using 
immunohistochemistry and SEM (Fig. 5.) showed variable but 
widespread staining for DNA, and histones were also present 
though not so widely dispersed and in some cases were 
coincident with fibrin aggregates. Based on these findings, 
model thrombi containing DNA ± histones were used to study 
the effect of NET components on clot structure and 
fibrinolysis, as described in the next sections. 
Figure 5. Fibrin, histone and DNA content of arterial 
thrombi. The thrombi rich in red blood cells (TO) or in 
fibrin (GI) according to the SEM images showed limited 
DNA- and histone-positive regions in contrast to the 
leukocyte-rich (TJ) thrombus. Scale bars: 50 µm in 
confocal panels, 2 µm in SEM panels. H1: histone H1. 
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Structural studies and thrombin inactivation kinetics 
At low concentrations of thrombin, the presence of histones 
enhanced the otherwise small effects of DNA on fibre diameter 
values resulting in the appearance of thicker fibres, while at 
higher thrombin concentrations DNA and histones alone had 
opposing effects in a plasma environment: DNA caused 
thickening of fibres, while histones caused a decrease of 
diameter values.  
 In fibrin clots, the presence of histones increased the 
permeability constant approximately 4-fold, even in the 
presence of additional DNA. In the more complex plasma 
environment, however, the opposite effect was seen: the 
presence of histones reduced KS values by almost 50%. The 
effect of DNA alone on clot permeability was consistent in 
both systems: a significant negative effect was observed. 
 Since thrombin concentrations alone are also able to 
influence structural parameters of clots, the effects of NET 
constituents on the inactivation of thrombin by antithrombin 
were investigated. Histones were effective in protecting 
thrombin from inactivation even in the presence of heparin, and 
increasing concentrations of DNA were able to partially 
attenuate this effect in the presence of physiological 
antithrombin concentration.  
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Viscoelastic properties of clots containing NET components 
Striking differences were seen in the shear stress necessary to 
disassemble the fibrin as presented in Fig. 6. In the presence of  
DNA alone the curves can be interpreted as increased 
sensitivity of fibrin to mechanical shear so that the shear stress 
needed to disassemble fibrin (where viscosity approaches zero) 
is reduced in comparison to the situation without DNA. 
However, when histones are added to fibrin, and to a greater 
extent when histones are added to fibrin+DNA, the clots 
become more stable and resistant to shear forces. 
 
B 
Figure 6. Rheometer studies showing the effect of DNA and 
histones on the critical shear stress needed to disassemble 
fibrin. Red: pure fibrin; green, magenta, blue, black: fibrin 
containing 50 and 100 µg/ml DNA, 300 µg/ml histone, 
histone+100 µg/ml DNA, respectively. τ: shear stress, η: 
viscosity. 
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Studies on lysis of plasma clots 
 
According to confocal microscopy, DNA and histones alone 
had a negligible effect on the tPA-front penetration in plasma 
clots, however, when both components were added 
simultaneously, the relative run distance of the lysis front after 
30 minutes was reduced by approximately 25%.  
Plasminogen activation assays on plasma clot surface 
using chromogenic substrate SPPL showed that apparent 
velocity of p-nitroaniline formation detected at A405 was 
reduced by DNA alone by 20%, while histones ± DNA 
increased this value. 
Turbidimetry assays revealed that DNA and histones 
prolonged the average time elapsed until 90% clot lysis when 
added separately or together, while the time needed for 50% 
lysis remained mostly unchanged, and ITC studies showed that 
FDPs (>150 kDa) bind to both DNA and histones with a higher 
affinity than fibrinogen and plasminogen, possibly contributing 
to the retardation of lysis in the presence of these NET 
constituents. 
 Presence of NETs generated by phorbol-myristate-
acetate (PMA)-activated granulocytes incorporated in the clots 
reproduced the effect of isolated components (Fig. 7.): T10 
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increased approximately 2-fold, while T50 was unaffected. 
NETosis inhibitor Cl-Amidine moderated the NET effects on 
T10 values (Fig. 7, inset).  
   
While incorporation of histones ± DNA did not 
influence plasmin-induced microscopic lytic front movement 
velocity in IBIDI slides, DNA alone reduced front velocity by 
40%, in line with the DNA-mediated enhancement of the 
defibrinogenated plasma-induced inactivation of plasmin. 
Figure 7. tPA-induced lysis of clots containing activated 
neutrophils. Clots were prepared as described in Materials and 
Methods. A340 turbidity values were normalized and converted to 
clot integrity. Mean curves of 8 measurements from a 
representative experiment are shown. Inset: Effect of Cl-
Amidine and its vehiculum dimethylsulphoxide (DMSO) on T10 
in clots containing PMA-activated neutrophils. T10 values are 
normalized for control to give relative units. Mean and standard 
deviation of means of 3 experiments with 6-8 parallels is shown. 
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CONCLUSIONS 
 
(1) Stretching of fibrin results in structural changes: a thinner 
fibres and diminished pores are formed. The distribution of 
these parameters is more homogeneous in stretched clots 
compared to that of non-stretched clots. 
(2) Structural changes are accompanied by decreased lytic 
susceptibility of stretched fibrin clots: tPA- as well as plasmin-
mediated lysis is hindered on the stretched substrate. 
(3) Major NET components (DNA and histones) are present in 
arterial thrombi. 
(4) Presence of DNA and histones in clots formed with low 
concentrations of thrombin results in the formation of thicker 
fibres. DNA alone decreases permeability, while histones have 
opposing effects in the purified and plasma systems (positive 
and negative effect, respectively).  
(5) Histones slow down the antithrombin-mediated inactivation 
of thrombin even in the presence of heparin, while the addition 
of DNA partially reverses this effect. 
(6) DNA alone decreases mechanical stability of fibrin clots, 
histones ± DNA increase clot resistance against shear forces. 
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(7) Plasma clots containing either NETs from activated 
neutrophils or purified NET components (DNA ± histones) are 
resistant to tPA-mediated lysis, while DNA alone hinders 
plasmin-induced lysis. 
(8) Retardation of fibrinolysis by NET constituents is partially 
elucidated by their affinity towards fibrin degradation products. 
Binding of DNA and histone to these clot fragments may 
contribute to hindered disassembly of thrombi. 
 
Implications: 
(1) Our findings indicate that intravascular thrombi exposed to 
increased circulatory shear forces (e.g. in bifurcations) might 
be more difficult to dissolve. Our results also add to the earlier 
observations that thrombi going through the process of 
retraction (platelet contraction leading to stretching of the 
fibrin network) are less susceptible to fibrinolysis.  
(2) Disruption of the DNA-histone matrix of thrombi (e.g. by 
DNAses or proteases capable of histone degradation, such as 
activated protein C) may enhance the effectiveness of current 
thrombolytic therapies aiming the dissolution of the fibrin 
meshwork. 
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